Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. On the other hand, non-genetic intra-tumoral heterogeneity, the cellular differentiation state, and the interaction between subclonal evolution and transcriptional heterogeneity, on the other hand, are poorly understood. The authors performed single-cell RNA sequencing on 14 untreated PCa patients in this study. They developed a comprehensive cell atlas of PCa patients and mapped developmental states onto tumor subclonal evolution. They find distinct subclones in PCa patients and then divide tumor cells into four transcriptional subtypes: EMT-like (subtype 0), luminal A-like (subtype 1), luminal B/C-like (subtype 2), and basal-like (subtype 3). These subtypes are organized hierarchically into stem cell-like and differentiated states. Surprisingly, multiple subclones within a single primary tumor have distinct preferential subtype combinations. Furthermore, subclones exhibit varying levels of communication with other cell types within the tumor ecosystem, which may modulate the distinct transcriptional subtypes of the subclones. Notably, they discovered that tumor cell transcriptional heterogeneity and cellular ecosystem diversity correlate with features of a poor prognosis by integrating TCGA data. Their research examines subclonal and transcriptional heterogeneity and its implications for patient prognosis.
The Beijing Winter Olympics Has Raised The Curtain On Feb 4, 2022May 19, 2022The Beijing Winter Olympics has raised the curtain on Feb 4, 2022, as thousands of athletes from across the globe gather in China for the first international multi-sport event to be held as scheduled ...view
What Are Microfluidic Platforms?November 10, 2023Microfluidic platforms are a powerful and innovative technology that is revolutionizing a wide range of industries. These platforms are designed to handle and process small amounts of fluids, often on...view
Next Generation Sequencing (NGS) TechnologyApril 8, 2024Next Generation Sequencing (NGS), also known as high-throughput sequencing, revolutionized the field of genomics. Unlike traditional Sanger sequencing methods, NGS allows researchers to analyze vast a...view
A Deep Dive into CapitalBio's LuxScan TechnologyFebruary 8, 2024Microarrays have revolutionized the field of life sciences, enabling researchers to analyze thousands of genes simultaneously. This technology underpins advancements in various fields, from drug disco...view
The Development History of Genetic Sequencer InstrumentApril 4, 2023The first generation of DNA genetic sequencer technologyIn 1977, Sanger proposed the classic dideoxy nucleotide termination sequencing method. Subsequently, based on the Sanger method, in the mid-1980...view